Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic. August 30, 2019 Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India September 3, 2020 BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers. May 3, 2016 Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres August 30, 2019 From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girl September 3, 2020
Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic. August 30, 2019
Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India September 3, 2020
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres August 30, 2019
From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girl September 3, 2020